October 2021 - Page 2 of 4 - BioMedWire (BMW)

ThursdayOct 21, 2021 9:48 am

OSA Predisposes People to Metabolic Defects, Study Finds

Obstructive sleep apnea ("OSA") predisposes individuals to type 2 diabetes and hyperglycemia, despite research showing that positive airway pressure doesn’t boost glucose dysregulation markers. This sleep disorder has been linked to impaired glucose disposal. During a recent presentation, University of Miami Miller School of Medicine’s chief of division of pulmonary, sleep medicine and critical care Naresh M. Punjabi stated that obstructive sleep apnea also impaired insulin and was linked to changes in free fatty acid kinetics. Punjabi explained that prior research had found that sleep apnea could speed up betacell compensation to insulin resistance, in addition to inducing insulin resistance.…

WednesdayOct 20, 2021 1:42 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Application Amid ‘New Era’ of Psychedelic Medicine

Substances such as psilocybin, ketamine and LSD are edging into mainstream culture, setting the stage for a paradigm shift in modern medicine Cybin has filed an international patent application covering methods for the delivery of psychedelic medications by inhalation The company is pursuing the effectiveness of using inhalation as a delivery method for psychedelic medications Earlier this month, a Time magazine article reported on the “new era” of psychedelic medicine (https://ibn.fm/bfC3u). On the leading edge of this collective breakthrough is Cybin (NEO: CYBN) (NYSE American: CYBN), a company focused on progressing psychedelic therapeutics, addressing the mental health crisis and transforming the…

WednesdayOct 20, 2021 9:30 am

Tips, Advantages of Adopting Data Analytics in Healthcare

Data analytics is the process of collecting, transforming and modelling data with the objective being to discover useful information that will help in decision making. Data analytics helps organizations make sense of data, which could help explain why more healthcare organizations have been adopting the use of data analytics. This process helps to not only improve their margins as well as efficiency but also drive better patient outcomes and care. Below are a few tips and advantages that healthcare leaders who are looking at adopt data analytics should consider. Ask for real-time data Data analytics affords you access to trends…

TuesdayOct 19, 2021 9:30 am

Israeli Researchers Find Immune Cells Aiding Tumor Development

Researchers from the Tel Aviv University have discovered that some immune cells in the body of a patient with cancer stop fighting cancer after a time and instead begin protecting the tumor. This breakthrough by the Israeli researchers could enhance the efficacy of treatments for cancer, in particular brain cancer. The researchers’ findings were reported in the “Cell Reports” journal. The researchers found that these white blood cells, known as neutrophils, are effective in killing fungi and bacteria. Normally, these cells initially fight against glioblastoma before they stop and instead begin to protect the tumor, helping it grow. Glioblastoma is…

MondayOct 18, 2021 12:41 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Announce Beta Launch of Proprietary ‘MiBoKo’ Metabolic Health Program

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the beta launch of MiBoKo, a combined application and non-invasive glucose sensor designed to help users track their metabolic scores US diabetes-related healthcare expenditures totalled $760 billion in 2019 alone, equating to an annual spend of over $9,000 per diabetic patient Nemaura Medical (NASDAQ: NMRD) is a cutting-edge medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company recently carried out the beta launch of MiBoKo, a new proprietary metabolic health program…

MondayOct 18, 2021 9:30 am

Study Finds That Substance-Use Disorders Heighten Risk of SARS-CoV-2 Breakthrough Infections

A recently conducted study has found that while the risk of SARS-CoV-2 breakthrough infection was low in vaccinated individuals with substance-use disorders, it was higher than the risk of vaccinated individuals who don’t suffer from substance use disorders. The research was conducted by researchers at the National Institute on Drug Abuse and was reported in “World Psychiatry.” Researchers from Case Western Reserve University also took part in the study. The researchers also discovered that adverse socioeconomic determinants of health, which are common in individuals suffering from substance use disorder and health conditions that occurred simultaneously, were primarily responsible for the…

FridayOct 15, 2021 9:36 am

Study Finds That Pandemic Caused Significant Increase in Mental Health Disorders

Prior to the COVID-19 pandemic, anxiety disorders and major depressive disorder were already huge contributors to the worldwide burden of disease, impacting millions of individuals across the globe. Now, a recent study has found that the coronavirus pandemic has caused a significant increase in major anxiety and depressive disorders globally. For this study, researchers identified more than 5,600 unique sources of data, almost 50 of which met the inclusion criteria. Most of the studies included were from North America and Western Europe, with a few from Central Europe, East Asia, the Asia-Pacific and Australasia also included in the analysis. The…

FridayOct 15, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with University of Wisconsin Researchers for Clinical Pharmacology Studies Evaluating TRP-8803

Tryp Therapeutics has partnered with Dr. Paul Hutson and Dr. Christopher Nicholas, researchers at the University of Wisconsin-Madison The collaboration will focus on a clinical pharmacology studies to evaluate the safety and pharmacokinetics of TRP-8803, Tryp’s proprietary drug formulation The partnership is the latest in a series of collaborations as the company prepares for Phase 2b trials Tryp intends to use data from its Phase 2a clinical studies, expected to launch this year, coupled with preclinical data and clinical pharmacology data for TRP-8803, to support the use of the novel drug formulation in Phase 2b trials Tryp Therapeutics (CSE: TRYP)…

ThursdayOct 14, 2021 2:00 pm

Shining the Spotlight on Binge-Eating Disorder

Research shows that binge-eating disorder, which is more common than other eating disorders such as bulimia and anorexia, affects more women than men. Experts say that despite popular opinion that binge eating is a mood or phase, it is a serious issue that needs to be addressed. Regence BlueCross BlueShield’s executive medical director Dr. Amy Khan states that eating disorders often represent serious mental health conditions. Khan explains that eating disorders are serious ailments that can impact an individual’s social, emotional and physical functioning. This is in addition to affecting their cardiovascular health and causing gastrointestinal issues. The disorders are…

WednesdayOct 13, 2021 11:38 am

Second-, Third-Degree Relatives of Colon Cancer Patients at Risk of Developing the Ailment

A new study has discovered that having relatives who have colorectal cancer heightens an individual’s risk of developing this ailment. This study, which was conducted by researchers from the University of Utah and the University of Buffalo, was published in the “Cancer Epidemiology” journal. Physicians recommend that first-degree relatives of individuals diagnosed with early onset colorectal cancer begin screening before they reach 50 years of age. This is mainly because cases of early onset colorectal cancer have increased considerably in the last few decades. The research suggests that early screening may benefit second- and third-degree relatives as well. First-degree relatives…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

Month: October 2021

OSA Predisposes People to Metabolic Defects, Study Finds

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Application Amid ‘New Era’ of Psychedelic Medicine

Tips, Advantages of Adopting Data Analytics in Healthcare

Israeli Researchers Find Immune Cells Aiding Tumor Development

Nemaura Medical Inc. (NASDAQ: NMRD) Announce Beta Launch of Proprietary ‘MiBoKo’ Metabolic Health Program

Study Finds That Substance-Use Disorders Heighten Risk of SARS-CoV-2 Breakthrough Infections

Study Finds That Pandemic Caused Significant Increase in Mental Health Disorders

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with University of Wisconsin Researchers for Clinical Pharmacology Studies Evaluating TRP-8803

Shining the Spotlight on Binge-Eating Disorder

Second-, Third-Degree Relatives of Colon Cancer Patients at Risk of Developing the Ailment

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search